Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Bryostatin 1 in combination with Vincristine for recurrent or refractory AIDS-related lymphomas has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Burkitt Lymphoma
• Aids-related Diffuse Large B-cell Lymphoma
• Aids-related Systemic Non-hodgkin Lymphoma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma | Phase 1 | Status: COMPLETED